Evidence map›Paper›PMID 31239659›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2019

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD.

Timothy E Albertson, Willis S Bowman, Richart W Harper, Regina M Godbout, Susan Murin

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Timothy E AlbertsonDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, UC Davis, Sacramento, CA, USA.
Willis S BowmanDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, UC Davis, Sacramento, CA, USA.
Richart W HarperDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, UC Davis, Sacramento, CA, USA.
Regina M GodboutDepartment of Veterans Affairs, Northern California Health Care System, Mather, CA, USA.
Susan MurinDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, UC Davis, Sacramento, CA, USA.
University of California, Davis · USVA Northern California Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of inhaled, fixed-dose, long-acting muscarinic antagonists (LAMA) combined with long-acting, beta

Indexed as

Administration, InhalationAdrenergic beta-2 Receptor AgonistsBenzyl AlcoholsBronchodilator AgentsChlorobenzenesDrug CombinationsDry Powder InhalersEvidence-Based MedicineHumansLungMuscarinic AntagonistsPulmonary Disease, Chronic ObstructiveQuinuclidinesRecovery of FunctionTreatment OutcomeAdrenergic beta-2 Receptor AgonistsBenzyl AlcoholsBronchodilator AgentsChlorobenzenesDrug CombinationsGSK573719Muscarinic AntagonistsQuinuclidinesvilanterolCOPDfixed-dose combination inhalersLABALAMAlong-acting beta2-adrenergic agonistslong-acting muscarinic antagonistsumeclidinium bromidevilanterol trifenatate

Identifiers

PMID31239659
PMCPMC6559138
OpenAlexW2948537122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.